Mir A. Ali

发表

Role of the JNK Pathway in Varicella-Zoster Virus Lytic Infection and Reactivation

Labchan Rajbhandari, A. Venkatesan, J. Cohen, 2017, Journal of Virology.

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

G. Marti, A. Wiestner, J. Cohen, 2020, Blood.

Varicella-Zoster Virus Immediate-Early 63 Protein Interacts with Human Antisilencing Function 1 Protein and Alters Its Ability To Bind Histones H3.1 and H3.3

P. Adams, J. Cohen, M. Gershon, 2008, Journal of Virology.

Insulin Degrading Enzyme Induces a Conformational Change in Varicella-Zoster Virus gE, and Enhances Virus Infectivity and Stability

E. Fischer, Qingxue Li, J. Cohen, 2010, PloS one.

Altered Antibody Profiles against Common Infectious Agents in Chronic Disease

M. Iadarola, S. Holland, J. Kovacs, 2013, PloS one.

Activation of H2AX and ATM in varicella-zoster virus (VZV)-infected cells is associated with expression of specific VZV genes.

Xueqiao Liu, J. Cohen, Takenobu Yamamoto, 2014, Virology.

Ganetespib, an HSP90 inhibitor, kills Epstein–Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood

D. Proia, J. Trepel, Kennichi C. Dowdell, 2017, Leukemia & lymphoma.

Periodic Illness Associated With Epstein-Barr Virus: A New Diagnosis After a 22-Year Follow-up.

J. Cohen, L. Dropulic, Mir A. Ali, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus (HSV) Seronegative Recipients of the HSV529 Vaccine.

Makinna Oestreich, P. Daugherty, Kennichi C. Dowdell, 2021, The Journal of infectious diseases.

Xenotropic murine leukemia virus-related virus is not associated with chronic fatigue syndrome in patients from different areas of the us in the 1990s

C. Kozak, J. Cohen, F. Miller, 2011, Virology Journal.

Detection of molluscum contagiosum virus (MCV) DNA in the plasma of an immunocompromised patient and possible reduction of MCV DNA with CMX-001.

A. Freeman, J. Cohen, E. Cowen, 2012, The Journal of infectious diseases.

Nectin-1 Is an Entry Mediator for Varicella-Zoster Virus Infection of Human Neurons

Labchan Rajbhandari, A. Venkatesan, Qingxue Li, 2021, Journal of virology.

The Amino Terminus of Varicella-Zoster Virus (VZV) Glycoprotein E Is Required for Binding to Insulin-Degrading Enzyme, a VZV Receptor

Wei-Jen Tang, Qingxue Li, J. Cohen, 2007, Journal of Virology.

Investigation of molluscum contagiosum virus, orf and other parapoxviruses in lymphomatoid papulosis.

J. Cohen, I. Damon, Hui Zhao, 2013, Journal of the American Academy of Dermatology.

Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation.

E. Jaffe, J. Cohen, H. Katano, 2004, Blood.

Insulin Degrading Enzyme Is a Cellular Receptor Mediating Varicella-Zoster Virus Infection and Cell-to-Cell Spread

Qingxue Li, J. Cohen, Mir A. Ali, 2006, Cell.

Absence or Overexpression of the Varicella-Zoster Virus (VZV) ORF29 Latency-Associated Protein Impairs Late Gene Expression and Reduces VZV Latency in a Rodent Model

J. Cohen, T. Krogmann, L. Pesnicak, 2006, Journal of Virology.

Detection of Antibodies to Varicella-Zoster Virus in Recipients of the Varicella Vaccine by Using a Luciferase Immunoprecipitation System Assay

J. Cohen, P. Burbelo, Ho-Jung Park, 2014, Clinical and Vaccine Immunology.

Detection of Antibodies to Varicella-Zoster Virus in Recipients of the Varicella Vaccine 1

J. Cohen, S. Steinberg, Mir A. Ali, 2014 .

System Assay by Using a Luciferase Immunoprecipitation Virus in Recipients of the Varicella Vaccine Detection of Antibodies to Varicella-Zoster

J. Cohen, Ho-Jung Park, A. Gershon, 2014 .

Comparison of levels of nasal, salivary, and plasma antibody to SARS-CoV-2 during natural infection and after vaccination.

T. Palmore, C. Spalding, J. Cohen, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge.

J. Cohen, T. Krogmann, L. Pesnicak, 2004, Vaccine.

The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection.

E. Fischer, Qingxue Li, J. Cohen, 2009, Virology.

Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's Tyrosine Kinase Inhibitor (BTK-I)

A. Wiestner, J. Cohen, I. Ahn, 2019, Blood.

Activation of H2AX and ATM in varicella-zoster virus (VZV)-infected cells is associated with expression of specific VZV genes.

Xueqiao Liu, J. Cohen, Takenobu Yamamoto, 2014, Virology.

BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL

A. Wiestner, J. Cohen, D. Koelle, 2022, Blood advances.